EpiPen’s pricing debacle and its impact on patients, insurers

A firestorm erupted this week in response to the phar­ma­ceu­tical com­pany Mylan’s sharp increase in the price of its EpiPen, a life-​​saving treat­ment for severe allergic reac­tions. The com­pany quickly back­tracked, announcing a rebate plan. Here, three North­eastern fac­ulty members—pharmacist Tayla Rose, health­care finance expert Steven Pizer, and health policy researcher Gary Young—explain the clin­ical, eco­nomic, and policy impli­ca­tions of the controversy.

Minority recruitment goals presented to Faculty Senate

The Office of Insti­tu­tional Diver­sity and Inclu­sion on Wednesday pre­sented to the Fac­ulty Senate an overview of the office’s goals to increase the number of under­rep­re­sented minori­ties working and studying on campus.

Employee benefits changes the focus at Faculty Senate

On Wednesday, university admin­is­tra­tors and fac­ulty mem­bers dis­cussed the planned changes for employees’ med­ical plan options and pledged to improve com­mu­ni­ca­tion in light of con­cerns that have arisen from the process.

A class project spurs health care mobility

North­eastern grad­uate stu­dents design a strategy to expand the impact of a mobile clinic offering Boston res­i­dents free health screen­ings and coaching.